872 related articles for article (PubMed ID: 25060590)
1. Evaluation of the WATCHMAN left atrial appendage closure device.
Alli O; Holmes D
Expert Rev Med Devices; 2014 Nov; 11(6):541-51. PubMed ID: 25060590
[TBL] [Abstract][Full Text] [Related]
2. Left atrial appendage-occluding devices for stroke prevention in patients with nonvalvular atrial fibrillation.
Yan BP; Kiernan TJ; Gonzales-Cruz I; Lam YY
Expert Rev Med Devices; 2009 Nov; 6(6):611-20. PubMed ID: 19911873
[TBL] [Abstract][Full Text] [Related]
3. The Left Atrial Appendage: Target for Stroke Reduction in Atrial Fibrillation.
Ramlawi B; Abu Saleh WK; Edgerton J
Methodist Debakey Cardiovasc J; 2015; 11(2):100-3. PubMed ID: 26306127
[TBL] [Abstract][Full Text] [Related]
4. Overview of the Food and Drug Administration circulatory system devices panel meetings on WATCHMAN left atrial appendage closure therapy.
Waksman R; Pendyala LK
Am J Cardiol; 2015 Feb; 115(3):378-84. PubMed ID: 25579887
[TBL] [Abstract][Full Text] [Related]
5. Left atrial appendage exclusion: state-of-the-art.
Cruz-Gonzalez I; Yan BP; Lam YY
Catheter Cardiovasc Interv; 2010 Apr; 75(5):806-13. PubMed ID: 20088009
[TBL] [Abstract][Full Text] [Related]
6. Left atrial appendage occlusion.
Alli O; Holmes D
Heart; 2015 Jun; 101(11):834-41. PubMed ID: 25518846
[TBL] [Abstract][Full Text] [Related]
7. A novel approach to left atrial appendage exclusion: the WATCHMAN device.
Gorodnitskiy A; Lucariello RJ; Aizer A; Coppola JT
Cardiol Rev; 2010; 18(5):230-3. PubMed ID: 20699670
[TBL] [Abstract][Full Text] [Related]
8. Endocardial (Watchman) vs epicardial (Lariat) left atrial appendage exclusion devices: Understanding the differences in the location and type of leaks and their clinical implications.
Pillarisetti J; Reddy YM; Gunda S; Swarup V; Lee R; Rasekh A; Horton R; Massumi A; Cheng J; Bartus K; Badhwar N; Han F; Atkins D; Bommana S; Earnest M; Nath J; Ferrell R; Bormann S; Dawn B; Di Biase L; Mansour M; Natale A; Lakkireddy D
Heart Rhythm; 2015 Jul; 12(7):1501-7. PubMed ID: 25778430
[TBL] [Abstract][Full Text] [Related]
9. Dealing With the Left Atrial Appendage for Stroke Prevention: Devices and Decision-Making.
Phillips KP; Paul V
Heart Lung Circ; 2017 Sep; 26(9):918-925. PubMed ID: 28652029
[TBL] [Abstract][Full Text] [Related]
10. [Percutaneous left atrial appendage closure with Watchman® LAA occluder device in a patient with persistent atrial fibrillation].
Kleczyński P; Sorysz D; Zawiślak B; Arif S; Bartuś S; Legutko J; Dubiel J; Dudek D
Kardiol Pol; 2012; 70(9):965-7. PubMed ID: 22993014
[TBL] [Abstract][Full Text] [Related]
11. The WATCHMAN device for stroke prophylaxis in atrial fibrillation: an evolving niche.
Couch G; Sabir I
Hosp Pract (1995); 2015; 43(1):13-21. PubMed ID: 25559429
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous closure of the left atrial appendage for thromboembolic prevention in atrial fibrillation.
Faustino A; Paiva L; Providência R; Cação R; Costa M; Leitão-Marques A
Rev Port Cardiol; 2013 Apr; 32(4):311-23. PubMed ID: 23528437
[TBL] [Abstract][Full Text] [Related]
13. [Interventional stroke prophylaxis : endocardial and epicardial left atrial appendage closure].
Rillig A; Heeger CH; Kuck KH; Tilz RR
Herz; 2015 Feb; 40(1):50-9. PubMed ID: 25604070
[TBL] [Abstract][Full Text] [Related]
14. Interventional treatments for stroke prevention in atrial fibrillation with emphasis upon the WATCHMAN device.
Möbius-Winkler S; Schuler GC; Sick PB
Curr Opin Neurol; 2008 Feb; 21(1):64-9. PubMed ID: 18180653
[TBL] [Abstract][Full Text] [Related]
15. Safety and Efficacy of Transcatheter Left Atrial Appendage Closure for Stroke Prevention in Patients with Atrial Fibrillation.
Price MJ
Prog Cardiovasc Dis; 2018; 60(4-5):542-549. PubMed ID: 29339165
[TBL] [Abstract][Full Text] [Related]
16. Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology: Final 2-Year Outcome Data of the EWOLUTION Trial Focusing on History of Stroke and Hemorrhage.
Boersma LV; Ince H; Kische S; Pokushalov E; Schmitz T; Schmidt B; Gori T; Meincke F; Protopopov AV; Betts T; Mazzone P; Foley D; Grygier M; Sievert H; De Potter T; Vireca E; Stein K; Bergmann MW;
Circ Arrhythm Electrophysiol; 2019 Apr; 12(4):e006841. PubMed ID: 30939908
[TBL] [Abstract][Full Text] [Related]
17. Assessment of Device-Related Thrombus and Associated Clinical Outcomes With the WATCHMAN Left Atrial Appendage Closure Device for Embolic Protection in Patients With Atrial Fibrillation (from the PROTECT-AF Trial).
Main ML; Fan D; Reddy VY; Holmes DR; Gordon NT; Coggins TR; House JA; Liao L; Rabineau D; Latus GG; Huber KC; Sievert H; Wright RF; Doshi SK; Douglas PS
Am J Cardiol; 2016 Apr; 117(7):1127-34. PubMed ID: 26993976
[TBL] [Abstract][Full Text] [Related]
18. Left atrial appendage occlusion with the WATCHMAN™ for stroke prevention in atrial fibrillation.
Price MJ
Rev Cardiovasc Med; 2014; 15(2):142-51. PubMed ID: 25051131
[TBL] [Abstract][Full Text] [Related]
19. [Interventional prevention of ischemic stroke].
Kamtchueng P; Teiger E
Ann Cardiol Angeiol (Paris); 2013 Dec; 62(6):411-8. PubMed ID: 24200350
[TBL] [Abstract][Full Text] [Related]
20. Stroke prevention in atrial fibrillation.
Mohammed I; Mohmand-Borkowski A; Burke JF; Kowey PR
J Cardiovasc Med (Hagerstown); 2012 Feb; 13(2):73-85. PubMed ID: 22193836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
